EB
CRVS icon

Eastern Bank’s Corvus Pharmaceuticals CRVS Stock Holding History

Eastern Bank’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37K Buy
+92
New +$1.28K ﹤0.01% 986

Other funds holding CRVS

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.57B AUM 35.56% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Eastern Bank's CRVS Position: Q2 2026 in Review

Eastern Bank opened a new position in Corvus Pharmaceuticals (CRVS) in Q2 2026: 92 shares worth $1.37K. The stake represents ﹤0.01% of the portfolio and ranks #986 among its holdings.

8 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.

  • Eastern Bank held 92 shares of Corvus Pharmaceuticals worth $1.37K as of Q2 2026.
  • Corvus Pharmaceuticals was a new Eastern Bank position in Q2 2026.
  • Corvus Pharmaceuticals made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #986 holding.
  • 8 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.